Health
Nivolumab and Chemotherapy for Mesothelioma is Focus of New Trial – Surviving Mesothelioma
Researchers in Germany are recruiting patients for a trial of nivolumab and chemotherapy for pleural mesothelioma patients after surgery.
Researchers in Germany are recruiting patients for a trial of nivolumab and chemotherapy for pleural mesothelioma patients who have had surgery.
Nivolumab (Opdivo) is an immunotherapy drug similar to pembrolizumab (Keytruda). It blocks a protein that helps mesothelioma cells hide from the immune system. Nivolumab is most often used for patients with non-small cell lung cancer.
The multicenter German study will test if a combination of nivolumab and chemotherapy can help keep tumors from growing…
-
General21 hours agoSearch underway for missing boat off South Australia’s Cape Jaffa
-
Noosa News22 hours agoQueensland coroner investigates ‘extremely unusual’ deaths of premature twin boys
-
Noosa News23 hours agoChristmas tragedy: NSW woman dies after alleged deliberate hit-and-run on Sunshine Coast
-
Noosa News24 hours agoUpdate: Attempted murder charges, Maroochydore